Clinical trial
Optimization of IV Ketamine for Treatment Resistant Depression
NCT00768430
Study timeline
Study start (unknown)2008-11-01Date precision: month
Registry last updated2014-01-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorder (MDD)unresolved
Treatment Resistant Depression (TRD)unresolved
Interventions
KetamineDRUG · verified · RxNorm: ketamine
MidazolamDRUG · verified · RxNorm: midazolam
Sponsors & collaborators
Baylor College of Medicinelead sponsor
Icahn School of Medicine at Mount Sinaicollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00768430 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.